Vol. 143, No. 41 — October 10, 2009
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999
Order 2009-87-09-02 Amending the Non-domestic Substances List
Whereas, pursuant to subsections 87(1) and (5) of the Canadian Environmental Protection Act, 1999 (see footnote a), the Minister of the Environment has added the substances referred to in the annexed Order to the Domestic Substances List (see footnote b);
Therefore, the Minister of the Environment, pursuant to subsections 87(1) and (5) of the Canadian Environmental Protection Act, 1999a, hereby makes the annexed Order 2009-87-09-02 Amending the Non-domestic Substances List.
Ottawa, September 24, 2009
JIM PRENTICE
Minister of the Environment
ORDER 2009-87-09-02 AMENDING THE NON-DOMESTIC SUBSTANCES LIST
AMENDMENTS
1. Part I of the Non-domestic Substances List (see footnote 1) is amended by deleting the following:
31288-93-4
36087-94-2
68390-93-2
70776-57-7
121315-16-0
124719-24-0
136793-29-8
164843-74-7
2. Part II of the List is amended by deleting the following:
17717-5
COMING INTO FORCE
3. This Order comes into force on the day on which Order 2009-87-09-01 Amending the Domestic Substances List comes into force.
[41-1-o]
CONSULTATIONS ON POSSIBLE FREE TRADE AGREEMENT NEGOTIATIONS WITH MOROCCO
The Government of Canada is seeking the views of Canadians on the scope of a possible free trade agreement (FTA) between Canada and the Kingdom of Morocco (Morocco).
This notice is part of the Government of Canada’s domestic consultation process with business, citizen-based organizations and individual Canadians, as well as with provincial and territorial governments, to obtain advice and views on priorities, objectives and concerns to help outline the parameters of this initiative.
Background
Canada and Morocco have recently engaged in an exchange on the possibility of FTA negotiations. Following an initial meeting in Rabat on January 8 and 9, 2009, a small team of Moroccan officials met with their Canadian counterparts in Ottawa on June 1 to 3, 2009, to assess the scope and desirability of possible FTA negotiations.
The commercial relationship between Canada and Morocco has grown stronger over the last decade. In 2008, bilateral merchandise trade totalled $452 million. Main Canadian exports consisted of wheat (primarily durum), iron and steel, and dried shelled pulses (lentils), while main Canadian imports were fruits and nuts (mostly citrus fruits), woven apparel, and mineral fuels and oils.
The Moroccan economy continues to develop and adjust to globalization. Significant economic reform is currently being implemented, including divestiture by the state, encouraged by international financial institutions. In 2008, Morocco’s economy grew by 5.6%. Morocco is experiencing an economic boom in industry and services, with the country becoming a hub for call centres and computer services. Morocco was the fourth-largest recipient of foreign direct investment in Africa in 2007, after South Africa, Nigeria and Egypt. The education sector is expanding, and there is strong potential for Canadian institutions, both Francophone and Anglophone.
As Canada’s first such agreement with an African country, an FTA with Morocco could be the gateway to a deepened Canadian commercial presence in the Mediterranean region and in North Africa. An FTA could better position Canadian business vis-à-vis competitors in this market and could provide increased market opportunities for Canadian goods and services into this growing market.
Morocco has an association agreement with the European Union (EU), which took effect on March 1, 2000, and an FTA with the United States that came into effect on January 1, 2006. Morocco’s association agreement with the EU provides for the complete dismantling of tariffs by 2012. Morocco has also concluded other FTAs with Tunisia, Egypt, Jordan (these four countries are signatories to the Agadir Declaration), the United Arab Emirates, the European Free Trade Association (Iceland, Liechtenstein, Norway and Switzerland — EFTA) and Turkey. Morocco is a member of the World Trade Organization (WTO) and the Greater Arab Free Trade Area (GAFTA).
Additional information on Canada’s relationship with Morocco can be found at
Submissions by interested parties
The Government is embarking on a public consultation process to allow all interested stakeholders an early opportunity to provide comments, input and advice on a possible free trade agreement with Morocco. It is essential that the Government of Canada be fully aware of the interests and potential sensitivities of Canadians with respect to this initiative. We welcome advice and views on any priorities, objectives and concerns relating to a possible free trade agreement with Morocco. In particular, we are seeking views with respect to the following:
All interested parties are invited to submit their views by November 2, 2009. Please be advised that any information received as a result of this consultation will be considered as public information, unless explicitly stated otherwise. Submissions should include
1. The contributor’s name and address and, if applicable, his/her organization, institution or business.
2. The specific issues being addressed.
3. Precise information on the rationale for the positions taken, including any significant impact it may have on Canada’s domestic or foreign interests.
Contributions can be sent by email to consultations@international.gc.ca, by fax at 613-944-3489 or by mail to Trade Negotiations Consultations (Morocco), Foreign Affairs and International Trade Canada, Regional Trade Policy Division (TBB), Lester B. Pearson Building, 125 Sussex Drive, Ottawa, Ontario K1A 0G2.
[41-1-o]
FOOD AND DRUGS ACT
Food and Drug Regulations — Amendments
Interim Marketing Authorization
Provision currently exists in the Food and Drug Regulations for the use of the enzyme lipase derived from various micro-organisms in the production of various food products, including bread and flour, at levels of use consistent with good manufacturing practices. The permitted sources of the lipase enzyme include the micro-organisms Aspergillus niger, Aspergillus oryzae, Mucor miehei, Penicillium camembertii, Rhizopus niveus and Rhizopus oryzae.
Health Canada has received a submission to permit the use of the phospholipase A2 enzyme derived from a genetically modified Aspergillus niger strain, Aspergillus niger (PLA-54), that carries the gene from a porcine pancreas coding for this enzyme. Phospholipase enzymes are classified under the broad class of lipase enzymes. This phospholipase A2 enzyme will be used in the production of bread, flour, whole wheat flour, unstandardized bakery products, unstandardized whole egg, unstandardized egg yolk and modified lecithin, at levels consistent with good manufacturing practice. Evaluation of the available data supports the safety and effectiveness of this phospholipase A2 derived from the genetically modified Aspergillus niger (PLA-54).
The use of this phospholipase A2 derived from this micro-organism will benefit the consumer by increasing the availability of quality food products. It will also benefit industry through more efficient and improved manufacturing conditions.
Therefore, it is the intention of Health Canada to recommend that the Food and Drug Regulations be amended to permit the use of this phospholipase A2 enzyme derived from Aspergillus niger (PLA-54) in the production of bread, flour, whole wheat flour, unstandardized bakery products, unstandardized whole egg, unstandardized egg yolk and modified lecithin, at levels consistent with good manufacturing practice.
As a means to improve the responsiveness of the regulatory system, an Interim Marketing Authorization is being issued to permit the immediate use of this phospholipase A2 enzyme, as indicated above, while the regulatory process is undertaken to amend the Regulations. The standardized foods described above are exempted from the application of sections 6 and 6.1 of the Food and Drugs Act, paragraphs B.01.042(a) and (c) and B.13.021(h), subparagraphs B.13.001(e)(iii) and B.13.005(d)(iii) and section B.16.007 of the Food and Drug Regulations. The unstandardized foods listed above are exempted from paragraph B.01.043(a) and section B.16.007 of the same Regulations.
The proposed regulatory amendments would be enabling measures to allow the sale of the foods mentioned above that have been manufactured through the use of the phospholipase A2 enzyme derived from Aspergillus niger (PLA-54). The amendments are supported by the safety assessment and would have low impact on the economy and on the environment. Consequently, the regulatory amendments may proceed directly to final approval and publication in the Canada Gazette, Part II.
Interested persons may make representations, with respect to Health Canada’s intention to amend the Regulations, within 75 days after the date of publication of this notice. All such representations must cite the Canada Gazette, Part I, and the date of publication of this notice, and be addressed to the contact person identified below.
Contact
Marie-Claude Tardif, Associate Director, Bureau of Food Regulatory, International and Interagency Affairs, Health Canada, 251 Sir Frederick Banting Driveway, Address Locator 2203B, Ottawa, Ontario K1A 0K9, 613-957-1750 (telephone), 613-941-6625 (fax), sche-ann@hc-sc.gc.ca (email).
September 29, 2009
MEENA BALLANTYNE
Assistant Deputy Minister
Health Products and Food Branch
[41-1-o]
Footnote a
S.C. 1999, c. 33
Footnote b
SOR/94-311
Footnote 1
Supplement, Canada Gazette, Part I, January 31, 1998
NOTICE:
The format of the electronic version of this issue of the Canada Gazette was modified in order to be compatible with extensible hypertext markup language (XHTML 1.0 Strict).